联合68Ga-PSMAHBED-CC摄取模式与同步PET/MRI衍生的多参数MRI在原发性前列腺癌诊断中的作用:初步经验
回顾性纳入35例男性(29个恶性、6个良性前列腺病灶),行同步全身68Ga-PSMAHBED-CC PET/MRI,于早期(7分钟)和延迟(54分钟)两个时间点测量PSMA摄取(SUV),并行PI-RADSv2评分。恶性病灶早期与延迟PSMA摄取差异有统计学意义(p < 0.01),鉴别良恶性病灶的AUC分别为0.83和0.94;PI-RADSv2联合PSMA摄取差异的AUC提高至0.99。双时相PSMA摄取可提高鉴别良恶性前列腺病灶的准确性,并补充多参数MRI对前列腺癌的诊断。
要点
- 延迟(54分钟)PSMA摄取鉴别前列腺良恶性病灶的AUC为0.94。
- 早期(7分钟)PSMA摄取鉴别前列腺良恶性病灶的AUC为0.83。
- PI-RADSv2联合PSMA摄取差异的AUC提高至0.99。
核心结论
- 双时相PSMA摄取可提高鉴别前列腺良恶性病灶的准确性,并补充多参数MRI对前列腺癌的诊断。
研究设计与样本
- 回顾性研究纳入35例男性,共29个恶性与6个良性前列腺病灶,均经完整临床评估包括组织学分析。
- 所有患者行同步全身68Ga-PSMAHBED-CC PET/MRI,采用PI-RADSv2 5分制评估癌的可能性。
- PSMA摄取于早期(7分钟)和延迟(54分钟)两个时间点记录,采用在MR图像上定义ROI的复制粘贴功能。
诊断标准与关键数值
- 恶性前列腺病灶早期与延迟PSMA摄取差异有统计学意义(p < 0.01),鉴别良恶性病灶的AUC分别为0.83和0.94。
- PI-RADSv2分类联合PSMA摄取差异鉴别前列腺病灶的AUC提高至0.99。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to assess whether temporal changes in 68Ga-prostate-specific membrane antigen (PSMA)-HBED-CC uptake and multiparametric MRI parameters derived using PET/MRI can aid in characterization of benign and malignant prostate lesions.
MATERIALS AND METHODS: Thirty-five men with 29 malignant and six benign prostate lesions undergoing complete clinical workup including histologic analysis were enrolled for this retrospective study. All had undergone simultaneous whole-body 68Ga-PSMAHBED-CC PET/MRI. Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) assessment was made using a 5-point scale showing the likelihood of cancer with the combination of multiparametric MRI findings. Gallium-68-PSMA uptake was recorded at two time points: early (7 minutes) and delayed (54 minutes), adopting a copy-and-paste function of the ROI defined on MR images. ROC curve analysis was performed to test the diagnostic accuracy of early versus delayed PSMA uptake (measured as maximum standardized uptake value [SUV]). A multiple-ROI analysis was done to obtain ROCs for combined PET SUV and multiparametric MRI datasets. Spearman analysis was performed to assess the correlations.
RESULTS: There was a significant difference between early and delayed PSMA uptake in malignant prostatic lesions (p < 0.01), which was able to characterize prostate lesions with an AUC of 0.83 and 0.94. Combined ROC analysis of PI-RADSv2 category derived from multiparametric MRI and differential PSMA uptake in characterizing prostatic lesions improved the AUC to 0.99.
CONCLUSION: Dual-phase PSMA uptake improves accuracy of classifying malignant versus benign prostate lesions and complements multiparametric MRI in the diagnosis of prostate cancer.
引用
- Taneja S, Jena A, Taneja R, et al. Effect of Combined 68Ga-PSMAHBED-CC Uptake Pattern and Multiparametric MRI Derived With Simultaneous PET/MRI in the Diagnosis of Primary Prostate Cancer: Initial Experience. AJR Am J Roentgenol. 2018. PMID: 29528713. doi:10.2214/AJR.17.18881
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。